吸烟者血清英夫利昔单抗谷浓度低及英夫利昔单抗抗体情况 - Suppr | 超能文献

Low trough serum infliximab and antibodies to infliximab in smokers.

作者信息

Kong Jee Yuen, Bundell Christine, Pawlik Janina, Hollingsworth Peter, Forbes Geoff

出版信息

Inflamm Bowel Dis. 2013 Mar;19(3):E35-6. doi: 10.1002/ibd.22928.

DOI:10.1002/ibd.22928

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Low trough serum infliximab and antibodies to infliximab in smokers.吸烟者血清英夫利昔单抗谷浓度低及英夫利昔单抗抗体情况

Inflamm Bowel Dis. 2013 Mar;19(3):E35-6. doi: 10.1002/ibd.22928.

2

The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab.英夫利昔单抗治疗炎症性肠病患者的抗药物抗体的时间演变。

Gut. 2014 Aug;63(8):1258-64. doi: 10.1136/gutjnl-2013-305259. Epub 2013 Sep 16.

3

Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment.在79例接受英夫利昔单抗维持治疗的炎症性肠病（IBD）患者队列中检测英夫利昔单抗谷浓度及抗英夫利昔单抗抗体。

J Crohns Colitis. 2014 Aug;8(8):881-9. doi: 10.1016/j.crohns.2014.01.009. Epub 2014 Jan 31.

4

Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease.英夫利昔单抗谷浓度及抗英夫利昔单抗抗体在克罗恩病中的临界值水平与诊断准确性

Scand J Gastroenterol. 2011 Mar;46(3):310-8. doi: 10.3109/00365521.2010.536254. Epub 2010 Nov 18.

5

Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease.患有炎症性肠病的哺乳期母亲乳汁中的英夫利昔单抗浓度。

J Crohns Colitis. 2014 Feb;8(2):175-6. doi: 10.1016/j.crohns.2013.09.003. Epub 2013 Oct 3.

6

Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD.抗英夫利昔单抗抗体与英夫利昔单抗水平降低和小儿炎症性肠病手术几率增加相关。

Inflamm Bowel Dis. 2015 Feb;21(2):307-14. doi: 10.1097/MIB.0000000000000284.

7

Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.根据英夫利昔单抗的血药浓度指导炎症性肠病患者的给药剂量。

Gastroenterology. 2015 Jun;148(7):1320-9.e3. doi: 10.1053/j.gastro.2015.02.031. Epub 2015 Feb 24.

8

Immunogenicity to infliximab is associated with HLA-DRB1.英夫利昔单抗的免疫原性与HLA - DRB1相关。

Gut. 2015 Aug;64(8):1344-5. doi: 10.1136/gutjnl-2015-309698. Epub 2015 Apr 15.

9

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis.经血清 infliximab 检测：infliximab 治疗急性溃疡性结肠炎临床结果的预测因子。

Gut. 2010 Jan;59(1):49-54. doi: 10.1136/gut.2009.183095.

10

[Inflammatory diseases of the intestines].

Rev Med Suisse. 2006 Jan 18;2(49):191-4, 196-8, 201-3.

引用本文的文献

1

Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies.引入免疫调节剂诱导的免疫系统代偿性适应的变异性模式：一种提高抗 TNF 治疗临床反应的新方法。

Front Immunol. 2019 Nov 20;10:2726. doi: 10.3389/fimmu.2019.02726. eCollection 2019.

2

Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.抗肿瘤坏死因子-α治疗克罗恩病失效与新炎症通路的出现无关。

Dig Dis Sci. 2018 Mar;63(3):738-745. doi: 10.1007/s10620-018-4932-8. Epub 2018 Jan 25.